In other words, the CXCL16/CXCR6 pathway between T cells and microglia may be an important target for the treatment of other neurological diseases and neurodegenerative diseases related to neuroinflammation in the central nervous system (50). This evidence concerns the gene CXCL16 and nervous system disorder.